Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathway
Deguelin exhibits antiproliferative activity against various cancer cell types. Previous studies have reported that deguelin exhibits pro-apoptotic activity against human cancer cells. The current study aimed at further elaborating the anticancer effects of deguelin against multiple myeloma cells. C...
Saved in:
Main Authors: | Sun Kening, Chen Ping, Zhang Liang, Lu Zhidong, Jin Qunhua |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2024-03-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2024-0003 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Electric Field Guided HaCaT Cell Migration Through the EGFR/p38 MAPK/Akt Pathway
by: Huajian Zhou, et al.
Published: (2024-12-01) -
Norcantharidin induces G2/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells
by: Huang Shuaishuai, et al.
Published: (2021-06-01) -
Adipose-derived stem cells promote the recovery of intestinal barrier function by inhibiting the p38 MAPK signaling pathway
by: Mei Yang, et al.
Published: (2025-01-01) -
CD2AP deficiency aggravates Alzheimer’s disease phenotypes and pathology through p38 MAPK activation
by: Yan-Yan Xue, et al.
Published: (2024-12-01) -
Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects
by: Alberto L. Horenstein, et al.
Published: (2025-02-01)